Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions-Reference-Cited by-同舟云学术

Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions

Published:2021-09 Issue: Volume:49 Page:100825
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Osman Afaf E.G.,Deininger Michael W.

Funder

Pfizer

Leukemia and Lymphoma Society

National Comprehensive Cancer Network

National Cancer Institute

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference178 articles.

1. Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib;Gambacorti-Passerini;J Natl Cancer Inst,2011

2. Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy;Huang;Cancer.,2012

3. Atomic bomb and leukemia;Ichimaru;J Radiat Res,1991

4. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis;Little;Radiat Res,1999

5. Neoplastic diseases induced by chronic alpha-irradiation-- epidemiological, biophysical and clinical results of the German Thorotrast Study;Van Kaick;JRadiatResTokyo.,1991

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Molecular Modeling of Four New Afatinib Derived Molecules Targeting the Inhibition of the Mutated Form of BCR-ABL T315I;Molecules;2024-09-08

2. Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers;Clinical and Translational Science;2024-09

3. Novel targeted therapies in chronic myeloid leukemia;Pharmaceutical Science Advances;2024-09

4. Gene Variants in Components of the microRNA Processing Pathway in Chronic Myeloid Leukemia;Genes;2024-08-10

5. SKF-96365 Expels Tyrosine Kinase Inhibitor-Treated CML Stem and Progenitor Cells from the HS27A Stromal Cell Niche in a RhoA-Dependent Mechanism;Cancers;2024-08-08